The Glutathione Man

 Dr Herbert T Nagasawa and Robert E Chan
Cellgevity
The Glutathione Man Up Cellgevity Details
 

 
 
 

 
Cellgevity™
Backed by decades of reputable science and research, Cellgevity™ is a proprietary blend superbly balanced with prime ingredients cells utilize for superior function for better health.

* Features Max’s patented RiboCeine™ technology that promotes natural production of Glutathione, the body’s master antioxidant.
* Includes 12 other highly effective prime nutrients that provide additional cellular
support for what cells need to naturally produce glutathione
* Replenishes cells with what they need to produce glutathione for effective detoxification of harmful toxins and free radicals
 
 
 
 

 

 
 

Cellgevity™ Brochure in English, Chinese & Malay
 

The Glutathione Man The Glutathione Story Glutathione Riboceine Max Products The Science Herbert T Nagasawa Max Research Team Users Testimonials Max Corporate Robert E Chan My Presentations FAQ Contact Us Beauty & Glamour Dr Robert H. Keller FusionExcel™

Malaysia

Contact me for the Best Prices & Delivery Options (I ship Worldwide)
Singapore

Max’s products are not intended for use in the cure,
mitigation, treatment or prevention of any disease

Today is

Visit counter For Websites  
 page views have been made on this website
 

Make Payment with PayPal (No Handling Charge)

Payment using Western Union Money Transfer

Payment with PayPal (No Handling Charge)

Other Money Transfer also acceptable

 

You are directed to view my Terms and Conditions of Use and Our Privacy Policy
Copyright © 1994–2024 The Glutathione Man - Robert E Chan. Serving you since 1994. All Rights Reserved.
The publication, reproduction, or distribution of any content on this website is strictly prohibited. All materials, including reports, images and logos, are my intellectual property. No part of this website may be copied, reproduced, modified, published, displayed, or used for commercial or other purposes without my prior written consent.
This webpage was updated on Monday, 25 November 2024